TMEM92 drives EMT-associated invasiveness, cisplatin resistance, and immune suppression in head and neck squamous cell carcinoma
Abstract Transmembrane protein 92 (TMEM92) has been implicated in tumor progression in several malignancies, yet its role in head and neck squamous cell carcinoma (HNSCC) remains unclear. Here, we systematically investigated the expression pattern, clinical relevance, and biological functions of TME...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Portfolio
2026-04-01
|
| Edice: | Scientific Reports |
| Témata: | |
| On-line přístup: | https://doi.org/10.1038/s41598-026-49694-7 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
